A Agilent Technologies | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.41 -0.8% | $135.00 ➝ $125.00 | Underweight ➝ Underweight | |
AAL American Airlines Group | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.50 +0.5% | $20.00 ➝ $16.50 | Buy ➝ Buy | |
ABL Abacus Life | Initiated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.41 +13.5% | $16.00 | Buy | |
ACIU AC Immune | Initiated by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.65 +17.1% | $8.00 | Buy | |
ACLX Arcellx | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $52.00 -0.5% | $70.00 | Overweight | |
ADC Agree Realty | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.76 +1.2% | $60.00 | Neutral | |
How Biden has already won 2024 (Ad) Obama’s Forever Term [Exposed] or Obama Biden has already won 2024
Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. Click here to watch this now before it’s too late. |
ADUS Addus HomeCare | Target Raised by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $114.81 +2.8% | $120.00 ➝ $128.00 | Overweight ➝ Overweight | |
AGO Assured Guaranty | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.72 +1.0% | $92.00 ➝ $87.00 | Market Perform ➝ Market Perform | |
ALLO Allogene Therapeutics | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.50 +1.6% | $11.00 | Overweight | |
AMBA Ambarella | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $90.00 ➝ $90.00 | Buy ➝ Buy | |
AMBA Ambarella | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $57.00 ➝ $67.00 | Overweight ➝ Overweight | |
AMBA Ambarella | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $65.00 ➝ $60.00 | Neutral ➝ Neutral | |
AMBA Ambarella | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $65.00 ➝ $55.00 | Equal Weight ➝ Equal Weight | |
AMSC American Superconductor | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.18 +10.0% | $16.00 ➝ $23.00 | Outperform ➝ Outperform | |
AMSC American Superconductor | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.18 +10.0% | $16.00 ➝ $23.00 | Buy ➝ Buy | |
AMSC American Superconductor | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.18 +10.0% | $15.00 ➝ $20.00 | Buy ➝ Buy | |
APD Air Products and Chemicals | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.70 +2.4% | $263.00 ➝ $276.00 | Outperform ➝ Outperform | |
APLS Apellis Pharmaceuticals | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $39.25 -3.7% | $46.00 | Neutral | |
ASAN Asana | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $17.00 ➝ $16.00 | Hold ➝ Hold | |
ASAN Asana | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $27.00 ➝ $27.00 | Market Outperform ➝ Market Outperform | |
ASAN Asana | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $28.00 ➝ $23.00 | Outperform ➝ Outperform | |
ASAN Asana | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $14.00 ➝ $13.00 | Underweight ➝ Underweight | |
ASAN Asana | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $18.00 ➝ $16.00 | Underweight ➝ Neutral | |
ASND Ascendis Pharma A/S | Initiated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.10 -1.7% | $200.00 | Buy | |
AVB AvalonBay Communities | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $192.68 +1.4% | $189.00 ➝ $210.00 | Overweight ➝ Overweight | |
BBY Best Buy | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.82 +4.0% | $80.00 ➝ $90.00 | In-Line ➝ In-Line | |
BBY Best Buy | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.82 +4.0% | $90.00 ➝ $95.00 | Buy ➝ Buy | |
BBY Best Buy | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.82 +4.0% | $87.00 ➝ $86.00 | Hold ➝ Hold | |
BHP BHP Group | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.53 +1.5% | | Buy ➝ Buy | |
BILI Bilibili | Upgraded by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.52 +0.7% | $11.90 ➝ $18.00 | Neutral ➝ Buy | |
BILL BILL | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.05 +1.5% | $74.00 ➝ $60.00 | Neutral ➝ Neutral | |
BIRK Birkenstock | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $62.00 | Neutral ➝ Neutral | |
BIRK Birkenstock | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $58.00 ➝ $65.00 | Outperform ➝ Outperform | |
BIRK Birkenstock | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $60.00 | Outperform ➝ Outperform | |
BIRK Birkenstock | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $63.00 | Outperform ➝ Outperform | |
BIRK Birkenstock | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $63.00 | Buy ➝ Buy | |
BRO Brown & Brown | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $89.51 +2.0% | $94.00 ➝ $100.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.65 +0.9% | $68.00 ➝ $62.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.65 +0.9% | $65.00 ➝ $52.00 | Buy ➝ Buy | |
BURL Burlington Stores | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $227.00 ➝ $240.00 | Outperform ➝ Outperform | |
How Biden has already won 2024 (Ad) Obama’s Forever Term [Exposed] or Obama Biden has already won 2024
Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. Click here to watch this now before it’s too late. |
BURL Burlington Stores | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $250.00 ➝ $274.00 | Outperform ➝ Outperform | |
BURL Burlington Stores | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $240.00 ➝ $275.00 | Overweight ➝ Overweight | |
BURL Burlington Stores | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $252.00 ➝ $274.00 | Overweight ➝ Overweight | |
BURL Burlington Stores | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $209.00 ➝ $257.00 | Hold ➝ Hold | |
BURL Burlington Stores | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $246.00 ➝ $284.00 | Overweight ➝ Overweight | |
BURL Burlington Stores | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $260.00 ➝ $275.00 | Outperform ➝ Outperform | |
BURL Burlington Stores | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $250.00 ➝ $275.00 | Buy ➝ Buy | |
BURL Burlington Stores | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $258.00 ➝ $276.00 | Buy ➝ Buy | |
BZH Beazer Homes USA | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.72 +4.5% | $37.00 | Outperform | |
CALT Calliditas Therapeutics AB (publ) | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.99 +4.0% | $39.00 | Buy ➝ Neutral | |
CBRL Cracker Barrel Old Country Store | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.78 +1.4% | $48.00 ➝ $42.00 | Sell ➝ Sell | |
CBRL Cracker Barrel Old Country Store | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.78 +1.4% | $51.00 ➝ $46.00 | Hold ➝ Hold | |
CCS Century Communities | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating | $84.41 +1.6% | $82.00 | Underperform ➝ Neutral | |
CDNA CareDx | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.01 -3.8% | | Neutral | |
CELC Celcuity | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.80 +4.6% | $24.00 ➝ $23.00 | Buy ➝ Buy | |
CHWY Chewy | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.21 -1.5% | $19.00 ➝ $22.00 | In-Line ➝ In-Line | |
CLLS Cellectis | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.71
| $6.00 ➝ $6.00 | Market Outperform ➝ Market Outperform | |
CM Canadian Imperial Bank of Commerce | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.54 -2.1% | $74.00 ➝ $77.00 | Outperform ➝ Outperform | |
CNOB ConnectOne Bancorp | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Switzer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $18.64 -1.4% | $24.00 ➝ $22.00 | Outperform ➝ Market Perform | |
COO Cooper Companies | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.31 +4.5% | | Hold | |
COO Cooper Companies | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.31 +4.5% | $116.00 ➝ $118.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Target Raised by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $800.00 ➝ $850.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $650.00 ➝ $676.00 | Neutral ➝ Neutral | |
COST Costco Wholesale | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $750.00 ➝ $775.00 | Equal Weight ➝ Equal Weight | |
COST Costco Wholesale | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $800.00 ➝ $875.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $777.00 ➝ $850.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $700.00 ➝ $765.00 | Equal Weight ➝ Equal Weight | |
COST Costco Wholesale | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $815.00 ➝ $873.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $845.00 ➝ $860.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $800.00 ➝ $850.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $710.00 ➝ $800.00 | Neutral ➝ Neutral | |
CPT Camden Property Trust | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.65 +1.6% | $92.00 ➝ $104.00 | Underweight ➝ Underweight | |
CRM Salesforce | Target Lowered by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $234.44 +7.5% | $330.00 ➝ $275.00 | Outperform ➝ Outperform | |
CTXR Citius Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.70 +6.1% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
CYTH Cyclo Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.28 -1.5% | $3.00 ➝ $3.00 | Buy ➝ Buy | |
DELL Dell Technologies | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $98.00 ➝ $97.00 | Underweight ➝ Underweight | |
DELL Dell Technologies | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $170.00 ➝ $175.00 | Overweight ➝ Overweight | |
DELL Dell Technologies | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $152.00 ➝ $155.00 | Overweight ➝ Overweight | |
DELL Dell Technologies | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $105.00 ➝ $155.00 | Hold ➝ Hold | |
DG Dollar General | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $147.00 ➝ $141.00 | Neutral ➝ Neutral | |
DG Dollar General | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $140.00 ➝ $135.00 | Hold ➝ Hold | |
DG Dollar General | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $161.00 ➝ $137.00 | Neutral ➝ Neutral | |
DG Dollar General | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $150.00 ➝ $140.00 | Market Perform ➝ Market Perform | |
DG Dollar General | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $150.00 ➝ $135.00 | Hold ➝ Hold | |
DGHI Digihost Technology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.32 +3.9% | $2.50 ➝ $2.50 | Buy ➝ Buy | |
DLTH Duluth | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.95 -0.3% | $5.00 ➝ $4.50 | Neutral ➝ Neutral | |
DLTR Dollar Tree | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.95 +2.8% | $160.00 ➝ $160.00 | Outperform ➝ Outperform | |
DSGX The Descartes Systems Group | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.33 +1.5% | $94.00 ➝ $96.00 | Market Perform ➝ Market Perform | |
DSGX The Descartes Systems Group | Target Raised by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.33 +1.5% | $100.00 ➝ $104.00 | Sector Outperform ➝ Sector Outperform | |
DXLG Destination XL Group | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.55 +7.6% | $3.50 ➝ $3.00 | Hold ➝ Hold | |
The only AI company to buy (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
DY Dycom Industries | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rygiel Subscribe to MarketBeat All Access for the recommendation accuracy rating | $179.96 -2.4% | $172.00 ➝ $205.00 | Buy ➝ Buy | |
EGP EastGroup Properties | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.18 +2.7% | $185.00 ➝ $175.00 | Neutral ➝ Neutral | |
ELEV Elevation Oncology | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.02 -1.2% | $10.00 | Overweight | |
ENPH Enphase Energy | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.90 -2.1% | $130.00 ➝ $150.00 | Buy ➝ Buy | |
EPRT Essential Properties Realty Trust | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.78 +1.2% | $30.00 | Buy | |
EQR Equity Residential | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.03 +1.8% | $66.00 ➝ $69.00 | Overweight ➝ Overweight | |
ESS Essex Property Trust | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $259.79 +1.6% | $232.00 ➝ $269.00 | Equal Weight ➝ Equal Weight | |
ESTC Elastic | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $128.00 ➝ $117.00 | Equal Weight ➝ Equal Weight | |
ESTC Elastic | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $130.00 ➝ $125.00 | Buy ➝ Buy | |
ESTC Elastic | Target Lowered by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $154.00 ➝ $135.00 | Sector Outperform ➝ Sector Outperform | |
ESTC Elastic | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $130.00 ➝ $120.00 | Buy ➝ Buy | |
ESTC Elastic | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $150.00 ➝ $140.00 | Buy ➝ Buy | |
ESTC Elastic | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | | Hold | |
ETR Entergy | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.49 +4.4% | $107.00 ➝ $114.00 | Buy ➝ Buy | |
FITB Fifth Third Bancorp | Upgraded by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.42 +1.8% | $43.00 | Peer Perform ➝ Outperform | |
FIVE Five Below | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.13 +2.5% | $220.00 ➝ $220.00 | Outperform ➝ Outperform | |
FL Foot Locker | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.73 +7.1% | $20.00 ➝ $24.00 | Equal Weight ➝ Equal Weight | |
FL Foot Locker | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.73 +7.1% | $22.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
FSLR First Solar | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $271.76 -1.8% | $230.00 ➝ $320.00 | Buy ➝ Buy | |
FSS Federal Signal | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.02 +5.5% | | Outperform | |
FTAI FTAI Aviation | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.32 +3.7% | $100.00 ➝ $100.00 | Buy ➝ Buy | |
GABC German American Bancorp | Target Raised by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.65 -0.8% | $33.00 ➝ $34.00 | Market Perform | |
GDDY GoDaddy | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.63 +1.0% | $150.00 ➝ $165.00 | Buy ➝ Buy | |
GNLX Genelux | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.71 +2.3% | $30.00 ➝ $25.00 | Speculative Buy ➝ Speculative Buy | |
GPS GAP | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $18.00 ➝ $23.00 | Market Perform ➝ Market Perform | |
GPS GAP | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $24.00 ➝ $32.00 | Outperform ➝ Outperform | |
GPS GAP | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $20.00 ➝ $27.00 | Neutral ➝ Neutral | |
GPS GAP | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $17.00 ➝ $28.00 | Hold ➝ Hold | |
GPS GAP | Target Raised by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $22.00 ➝ $29.00 | Market Perform ➝ Market Perform | |
GPS GAP | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $20.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
GPS GAP | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $23.00 ➝ $28.00 | Neutral ➝ Neutral | |
GPS GAP | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $15.50 ➝ $18.50 | Underperform ➝ Underperform | |
GREE Greenidge Generation | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.62 -7.7% | $6.00 ➝ $5.00 | Buy ➝ Buy | |
HRL Hormel Foods | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.98 +0.6% | $28.00 ➝ $29.00 | Underweight ➝ Neutral | |
HRL Hormel Foods | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.98 +0.6% | $32.00 ➝ $32.00 | Equal Weight ➝ Equal Weight | |
HRL Hormel Foods | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.98 +0.6% | $35.00 ➝ $33.00 | Neutral ➝ Neutral | |
HTLF Heartland Financial USA | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Delmonte Subscribe to MarketBeat All Access for the recommendation accuracy rating | $43.96 +2.1% | $51.00 ➝ $54.00 | Market Perform ➝ Outperform | |
HWC Hancock Whitney | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Mealor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $46.73 +1.6% | $50.00 ➝ $55.00 | Market Perform ➝ Outperform | |
IBTX Independent Bank Group | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.04 +0.1% | $38.00 ➝ $58.00 | Underweight ➝ Overweight | |
ICFI ICF International | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $142.75 +2.4% | $173.00 ➝ $173.00 | Outperform ➝ Outperform | |
ICLR ICON Public | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $324.82 +0.6% | | Outperform | |
ICLR ICON Public | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $324.82 +0.6% | $363.00 ➝ $367.00 | Outperform ➝ Outperform | |
ICLR ICON Public | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $324.82 +0.6% | $349.00 ➝ $373.00 | Buy ➝ Buy | |
IMNM Immunome | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $14.94 +1.6% | $27.00 | Overweight | |
INSM Insmed | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.05 -3.4% | $39.00 ➝ $67.00 | Buy ➝ Buy | |
IOVA Iovance Biotherapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.88 -1.3% | $32.00 ➝ $32.00 | Buy ➝ Buy | |
ITRM Iterum Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.50 +16.3% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
JWN Nordstrom | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $15.00 ➝ $18.00 | Underperform ➝ Underperform | |
JWN Nordstrom | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $19.00 ➝ $19.00 | Market Perform ➝ Market Perform | |
JWN Nordstrom | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $17.00 ➝ $19.00 | In-Line ➝ In-Line | |
The only AI company to buy (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
JWN Nordstrom | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $15.00 ➝ $18.00 | Underweight ➝ Underweight | |
KSS Kohl's | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $24.00 ➝ $22.00 | In-Line ➝ In-Line | |
KSS Kohl's | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $25.00 ➝ $20.00 | Neutral ➝ Neutral | |
KSS Kohl's | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $31.00 ➝ $25.00 | Buy ➝ Buy | |
KSS Kohl's | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $32.00 ➝ $27.00 | Outperform ➝ Outperform | |
LMAT LeMaitre Vascular | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $78.88 +0.1% | $100.00 | Buy | |
LMAT LeMaitre Vascular | Upgraded by | Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wittes Subscribe to MarketBeat All Access for the recommendation accuracy rating | $78.88 +0.1% | | Strong-Buy | |
LRMR Larimar Therapeutics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.00 +12.7% | $25.00 ➝ $25.00 | Market Outperform ➝ Market Outperform | |
LSEA Landsea Homes | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.92 +2.2% | $14.00 | Outperform | |
MAA Mid-America Apartment Communities | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.71 +3.0% | $129.00 ➝ $138.00 | Equal Weight ➝ Equal Weight | |
MAXN Maxeon Solar Technologies | Downgraded by | Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Schafer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.88 -7.4% | | Hold ➝ Strong Sell | |
MAXN Maxeon Solar Technologies | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.88 -7.4% | $3.00 ➝ $2.00 | Neutral ➝ Neutral | |
MAXN Maxeon Solar Technologies | Downgraded by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.88 -7.4% | $7.00 ➝ $0.50 | Market Perform ➝ Under Perform | |
MBI MBIA | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.65 -0.9% | $7.50 ➝ $6.50 | Market Perform ➝ Market Perform | |
MDB MongoDB | Upgraded by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Kessinger Subscribe to MarketBeat All Access for the recommendation accuracy rating | $236.06 -23.9% | | Hold ➝ Strong-Buy | |
MDB MongoDB | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $458.00 ➝ $290.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $415.00 ➝ $315.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $435.00 ➝ $300.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $480.00 ➝ $300.00 | Outperform ➝ Outperform | |
MDB MongoDB | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $440.00 ➝ $380.00 | Market Outperform ➝ Market Outperform | |
MDB MongoDB | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $435.00 ➝ $325.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $450.00 ➝ $300.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $465.00 ➝ $290.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $480.00 ➝ $350.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $455.00 ➝ $320.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $450.00 ➝ $305.00 | Outperform ➝ Outperform | |
MDB MongoDB | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $475.00 ➝ $300.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $380.00 ➝ $250.00 | Neutral ➝ Neutral | |
MFA MFA Financial | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.70 +1.5% | $12.50 ➝ $12.50 | Market Outperform ➝ Market Outperform | |
MGY Magnolia Oil & Gas | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.95 +1.9% | $33.00 ➝ $35.00 | Buy ➝ Buy | |
MOV Movado Group | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.50 +0.8% | $41.00 ➝ $41.00 | Buy ➝ Buy | |
MRO Marathon Oil | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +2.7% | $38.00 ➝ $29.00 | Overweight ➝ Equal Weight | |
MRVL Marvell Technology | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $71.00 ➝ $77.00 | Equal Weight ➝ Equal Weight | |
MRVL Marvell Technology | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $95.00 ➝ $95.00 | Buy ➝ Buy | |
MRVL Marvell Technology | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $75.00 ➝ $80.00 | Overweight ➝ Overweight | |
MRVL Marvell Technology | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $80.00 ➝ $90.00 | Outperform ➝ Outperform | |
MRVL Marvell Technology | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Muse Subscribe to MarketBeat All Access for the recommendation accuracy rating | $68.81 -10.5% | $85.00 ➝ $85.00 | Overweight ➝ Overweight | |
MRVL Marvell Technology | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $86.00 ➝ $90.00 | Buy ➝ Buy | |
MRVL Marvell Technology | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $88.00 ➝ $91.00 | Outperform ➝ Outperform | |
MRVL Marvell Technology | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $95.00 ➝ $100.00 | Buy ➝ Buy | |
MTZ MasTec | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.25 +0.8% | $120.00 ➝ $132.00 | Buy ➝ Buy | |
MU Micron Technology | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.00 -1.0% | $150.00 ➝ $155.00 | Buy ➝ Buy | |
NET Cloudflare | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.69 -0.4% | $135.00 ➝ $135.00 | Buy ➝ Buy | |
NET Cloudflare | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $67.69 -0.4% | $80.00 ➝ $80.00 | Neutral ➝ Neutral | |
NET Cloudflare | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.69 -0.4% | $108.00 ➝ $90.00 | Outperform ➝ Outperform | |
NGD New Gold | Initiated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.19 -0.5% | $3.00 ➝ $3.50 | Outperform ➝ Outperform | |
NNN NNN REIT | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.77 +2.0% | $41.00 | Neutral | |
NTAP NetApp | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $100.00 ➝ $116.00 | Equal Weight ➝ Equal Weight | |
NTAP NetApp | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $120.00 ➝ $135.00 | Buy ➝ Buy | |
NTAP NetApp | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $95.00 ➝ $125.00 | Underweight ➝ Neutral | |
Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad) In January 2021, Donald Trump silently rolled out a special gift to the American public…
One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. |
NTAP NetApp | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $120.00 ➝ $130.00 | Buy ➝ Buy | |
NTAP NetApp | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $130.00 ➝ $138.00 | Positive ➝ Positive | |
NTAP NetApp | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $100.00 ➝ $120.00 | Equal Weight ➝ Equal Weight | |
NXTC NextCure | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.54 -2.5% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
O Realty Income | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.06 +2.5% | $67.00 ➝ $61.00 | Buy ➝ Buy | |
OCFC OceanFirst Financial | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Switzer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $15.05 +2.9% | $19.00 ➝ $18.00 | Outperform ➝ Market Perform | |
OCUL Ocular Therapeutix | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.70 -1.7% | $15.00 | Overweight | |
ONCT Oncternal Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.21 +1.2% | $19.00 ➝ $19.00 | Buy ➝ Buy | |
PATH UiPath | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.26 +1.6% | $30.00 ➝ $19.00 | Buy ➝ Buy | |
PD PagerDuty | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.97 +5.7% | $27.00 ➝ $26.00 | Buy ➝ Buy | |
PENN PENN Entertainment | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.50 +19.6% | $27.00 ➝ $26.00 | Positive ➝ Positive | |
PHAR Pharming Group | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.15 +2.5% | $37.00 ➝ $37.00 | Buy ➝ Buy | |
PHAT Phathom Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.42 -7.6% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
PHR Phreesia | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $37.00 ➝ $34.00 | Buy ➝ Buy | |
PHR Phreesia | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $28.00 ➝ $28.00 | Overweight ➝ Overweight | |
PHR Phreesia | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $30.00 ➝ $30.00 | Market Outperform ➝ Market Outperform | |
PHR Phreesia | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $29.00 ➝ $29.00 | Buy ➝ Buy | |
PLD Prologis | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $110.49 +2.7% | $130.00 ➝ $120.00 | Neutral ➝ Neutral | |
PYPL PayPal | Initiated by | New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.99 +0.8% | $80.00 | Buy | |
QCOM QUALCOMM | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $204.05 -0.4% | $180.00 ➝ $240.00 | Buy ➝ Buy | |
QCOM QUALCOMM | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $204.05 -0.4% | $180.00 ➝ $245.00 | Buy ➝ Buy | |
QUAD Quad/Graphics | Initiated by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.72 +2.6% | $7.50 | Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $68.00 ➝ $72.00 | Outperform ➝ Outperform | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $107.00 ➝ $115.00 | Overweight ➝ Overweight | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $124.00 ➝ $127.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $83.00 ➝ $76.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $109.00 ➝ $111.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $47.00 ➝ $48.00 | Neutral ➝ Neutral | |
RBRK Rubrik | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $30.48 +0.7% | $50.00 | Overweight | |
REE REE Automotive | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.32 -1.6% | $15.00 ➝ $15.00 | Buy ➝ Buy | |
REXR Rexford Industrial Realty | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.36 +1.5% | $52.00 ➝ $50.00 | Neutral ➝ Neutral | |
ROIV Roivant Sciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.36 -0.3% | $18.00 ➝ $18.00 | Buy ➝ Buy | |
RSVR Reservoir Media | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Boss Subscribe to MarketBeat All Access for the recommendation accuracy rating | $8.04 -2.8% | $11.00 ➝ $11.50 | Buy ➝ Buy | |
S SentinelOne | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $29.00 ➝ $25.00 | Overweight ➝ Overweight | |
S SentinelOne | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $35.00 ➝ $29.00 | Buy ➝ Buy | |
S SentinelOne | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $33.00 ➝ $33.00 | Market Outperform ➝ Market Outperform | |
S SentinelOne | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $30.00 ➝ $23.00 | Buy ➝ Buy | |
S SentinelOne | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $35.00 ➝ $22.00 | Positive ➝ Positive | |
S SentinelOne | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $26.00 ➝ $19.00 | Equal Weight ➝ Equal Weight | |
S SentinelOne | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $29.00 ➝ $27.00 | Buy ➝ Buy | |
S SentinelOne | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $31.00 ➝ $25.00 | Overweight ➝ Overweight | |
S SentinelOne | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $27.00 ➝ $22.00 | Equal Weight ➝ Equal Weight | |
S SentinelOne | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $30.00 ➝ $25.00 | Buy ➝ Buy | |
SBCF Seacoast Banking Co. of Florida | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | W. Lay Subscribe to MarketBeat All Access for the recommendation accuracy rating | $23.67 +3.9% | $26.00 ➝ $27.00 | Market Perform ➝ Outperform | |
SCHW Charles Schwab | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28 +1.9% | $89.00 ➝ $81.00 | Overweight ➝ Overweight | |
SHAK Shake Shack | Reiterated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.89 +0.6% | $125.00 ➝ $125.00 | Buy ➝ Buy | |
SLDB Solid Biosciences | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.26 +8.1% | $20.00 | Overweight | |
SLDB Solid Biosciences | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.26 +8.1% | $12.00 ➝ $10.00 | Neutral ➝ Neutral | |
SLN Silence Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.99 -3.8% | $75.00 ➝ $75.00 | Buy ➝ Buy | |
SMMT Summit Therapeutics | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.69 -20.4% | $7.00 ➝ $13.00 | Buy ➝ Buy | |
SO Southern | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.14 +2.6% | $73.00 ➝ $79.00 | Neutral ➝ Neutral | |
SPTN SpartanNash | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.65 -0.9% | $22.00 ➝ $20.00 | Market Perform ➝ Market Perform | |
SRPT Sarepta Therapeutics | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $129.86 +4.3% | $157.00 | Overweight | |
STX Seagate Technology | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.24 -0.5% | $100.00 ➝ $110.00 | Buy ➝ Buy | |
SWTX SpringWorks Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.46 -2.7% | $74.00 ➝ $74.00 | Buy ➝ Buy | |
TBBB BBB Foods | Target Raised by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.24 +0.7% | $33.00 ➝ $36.00 | Sector Outperform ➝ Sector Outperform | |
UDR UDR | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.62 +2.0% | $39.00 ➝ $41.00 | Overweight ➝ Overweight | |
ULTA Ulta Beauty | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $630.00 ➝ $500.00 | Outperform ➝ Outperform | |
ULTA Ulta Beauty | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $505.00 ➝ $498.00 | Overweight ➝ Overweight | |
ULTA Ulta Beauty | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $500.00 ➝ $500.00 | Outperform ➝ Outperform | |
ULTA Ulta Beauty | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $540.00 ➝ $500.00 | Market Perform ➝ Market Perform | |
ULTA Ulta Beauty | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $530.00 ➝ $544.00 | Overweight ➝ Overweight | |
ULTA Ulta Beauty | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $520.00 ➝ $500.00 | Buy ➝ Buy | |
UMBF UMB Financial | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Mcgratty Subscribe to MarketBeat All Access for the recommendation accuracy rating | $82.44 +2.0% | $93.00 ➝ $98.00 | Market Perform ➝ Outperform | |
UNCY Unicycive Therapeutics | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.88 +4.8% | $3.00 ➝ $3.00 | Speculative Buy ➝ Speculative Buy | |
VALN Valneva | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.07 +1.9% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $235.00 ➝ $185.00 | Neutral ➝ Neutral | |
VEEV Veeva Systems | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $250.00 ➝ $210.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $220.00 ➝ $210.00 | Hold ➝ Hold | |
VEEV Veeva Systems | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $260.00 ➝ $260.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $245.00 ➝ $235.00 | Overweight ➝ Overweight | |
VEEV Veeva Systems | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $240.00 ➝ $204.00 | Neutral ➝ Neutral | |
VEEV Veeva Systems | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $210.00 ➝ $173.00 | Underweight ➝ Underweight | |
VEEV Veeva Systems | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Materne Subscribe to MarketBeat All Access for the recommendation accuracy rating | $174.25 -10.3% | $230.00 ➝ $200.00 | In-Line ➝ In-Line | |
VEEV Veeva Systems | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $245.00 ➝ $220.00 | Overweight ➝ Overweight | |
VERA Vera Therapeutics | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.99 +2.8% | $60.00 ➝ $65.00 | Overweight ➝ Overweight | |
VLY Valley National Bancorp | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Perito Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.13 +2.6% | $12.00 ➝ $8.00 | Outperform ➝ Market Perform | |
VRTX Vertex Pharmaceuticals | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $455.34 +2.8% | $480.00 ➝ $500.00 | Outperform ➝ Outperform | |
VSAT Viasat | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.89 +2.4% | $30.00 ➝ $23.00 | Overweight ➝ Overweight | |
VSTS Vestis | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.32 +1.7% | | Market Perform | |
WBA Walgreens Boots Alliance | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.22 +5.4% | $16.00 ➝ $13.00 | Underweight ➝ Underweight | |
WDC Western Digital | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.29 -0.3% | $80.00 ➝ $90.00 | Buy ➝ Buy | |
WHD Cactus | Downgraded by | Johnson Rice Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.35 +2.0% | | Buy ➝ Accumulate | |
WPC W. P. Carey | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.40 +0.6% | $57.00 | Neutral | |
XERS Xeris Biopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.26 +1.3% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
XFOR X4 Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.01 +3.1% | $5.00 ➝ $5.00 | Overweight ➝ Overweight | |
XOMA XOMA | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.79 +2.2% | $74.00 ➝ $74.00 | Buy ➝ Buy | |
XYL Xylem | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.02 +1.2% | $147.00 ➝ $152.00 | Outperform ➝ Outperform | |
ZBH Zimmer Biomet | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $115.15 +0.6% | $130.00 ➝ $125.00 | Underweight ➝ Underweight | |
ZS Zscaler | Target Lowered by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $250.00 ➝ $210.00 | Sector Outperform ➝ Sector Outperform | |
ZS Zscaler | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $225.00 ➝ $180.00 | Hold ➝ Hold | |
ZS Zscaler | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $205.00 ➝ $210.00 | Overweight ➝ Overweight | |
ZS Zscaler | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $290.00 ➝ $290.00 | Strong-Buy ➝ Strong-Buy | |
ZS Zscaler | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $240.00 ➝ $220.00 | Buy ➝ Buy | |
ZS Zscaler | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $270.00 ➝ $270.00 | Market Outperform ➝ Market Outperform | |
ZS Zscaler | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $215.00 ➝ $230.00 | Outperform ➝ Outperform | |
ZS Zscaler | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $200.00 ➝ $205.00 | Neutral ➝ Neutral | |
ZS Zscaler | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $258.00 ➝ $220.00 | Buy ➝ Buy | |
ZS Zscaler | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $275.00 ➝ $210.00 | Positive ➝ Positive | |
ZS Zscaler | Target Lowered by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $280.00 ➝ $270.00 | Outperform ➝ Outperform | |
ZS Zscaler | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $290.00 ➝ $260.00 | Outperform ➝ Outperform | |
ZS Zscaler | Target Lowered by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $169.96 +8.5% | $230.00 ➝ $200.00 | Neutral ➝ Neutral | |